BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)

284 filings reported holding BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) as of Q1 2021.
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) has 213 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29,716,757 shares of 239,647,920 outstanding shares and own 12.4% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (6,738,012 shares), PRIMECAP MANAGEMENT CO/CA/ (4,821,718 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,074,906 shares), FMR LLC (1,754,146 shares), Artisan Partners Limited Partnership (1,582,256 shares), Bill & Melinda Gates Foundation (1,038,674 shares), Artal Group S.A. (900,000 shares), BlackRock Inc. (742,858 shares), Temasek Holdings (Private) Ltd (537,634 shares), and DekaBank Deutsche Girozentrale (482,377 shares).
This table shows the top 213 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.